Sagimet Biosciences Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 16.3% | 16.3% | -92.3% |
| FY2023 | -30.6% | -30.6% | -28.8% |
| FY2024 | -29.2% | -29.2% | -28.4% |
| FY2025 | -45.8% | -45.8% | -43.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 16.3% | 16.3% | -92.3% |
| FY2023 | -30.6% | -30.6% | -28.8% |
| FY2024 | -29.2% | -29.2% | -28.4% |
| FY2025 | -45.8% | -45.8% | -43.8% |